A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials
- 30 November 2010
- journal article
- Published by Elsevier in Biologicals
- Vol. 38 (6) , 675-683
- https://doi.org/10.1016/j.biologicals.2010.09.001
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effects of a Reduced Dose Schedule and Intramuscular Administration of Anthrax Vaccine Adsorbed on Immunogenicity and Safety at 7 MonthsA Randomized TrialJAMA, 2008
- Interlaboratory Comparison of Results of an Anthrax Lethal Toxin Neutralization Assay for Assessment of Functional Antibodies in Multiple SpeciesClinical and Vaccine Immunology, 2008
- Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralizationJournal of Immunological Methods, 2008
- Countering Anthrax: Vaccines and ImmunoglobulinsClinical Infectious Diseases, 2008
- Appropriate calibration curve fitting in ligand binding assaysThe AAPS Journal, 2007
- Mass Value Assignment of Total and Subclass Immunoglobulin G in a Human Standard Anthrax Reference SerumClinical and Vaccine Immunology, 2004
- Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective AntigenEmerging Infectious Diseases, 2002
- Molecular pathogenesis of infectionMicrobes and Infection, 1999
- Internal quality assurance in a clinical virology laboratory. II. Internal quality control.Journal of Clinical Pathology, 1995
- STUDIES ON IMMUNITY IN ANTHRAX XJournal of Bacteriology, 1963